Jubilant Ingrevia reported a 41% year-on-year increase in consolidated net profit to ₹105.82 crore for the quarter ended June 30, 2026, up from ₹75.10 crore in the corresponding period of the previous year. The company's revenue from operations grew 25% to ₹1,300.27 crore, driven by strong performance across its Speciality Chemicals, Nutrition & Health Solutions, and Chemical Intermediates segments. The EBITDA margin expanded to 15.45% from 13.80% in the year-ago quarter, reflecting improved operational efficiency and better cost management.

Consolidated Financial Performance

The company's key financial metrics for the quarter ended June 30, 2026, compared to the same period last year are summarised below:

*Note: EBITDA is calculated as Profit Before Tax plus Depreciation and Amortisation and Finance Costs.

Segment and Operational Highlights

Revenue growth was broad-based, with Speciality Chemicals reporting ₹637.00 crore, Nutrition & Health Solutions at ₹243.82 crore, and Chemical Intermediates at ₹525.17 crore. The Board of Directors approved the unaudited standalone and consolidated financial results at a meeting held on July 22, 2026. The statutory auditors, Walker Chandiok & Co LLP, issued a limited review report confirming compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Ratios and Capital Allocation

The debt service coverage ratio improved to 4.81 times, while the interest service coverage ratio stood at 12.01 times for the quarter. The net profit margin increased to 8.07% from 7.16% in the previous year. During the quarter, the company granted 343,569 stock options to eligible employees as determined by the Nomination, Remuneration and Compensation Committee.

jubilant ingrevia Limited has scheduled an investor conference call on July 23, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026. The management team will address analysts and investors regarding the company's financial performance during the session, which begins at 05:00 pm IST.

The event will start with a brief management presentation, followed by an interactive Question & Answer session. Participants can join the discussion via specific dial-in numbers or through an audio link that will be available on the company's website.

Conference Call Details

Access Information

Investors can pre-register for the event to receive dial-in numbers, a passcode, and a PIN. The conference provides universal access numbers and toll-free options for participants in the USA, UK, Singapore, and Hong Kong.

The audio link for the conference call will be accessible on the company's investor relations page. Jubilant Ingrevia Limited is an integrated global Specialty Chemicals & CDMO company serving various sectors including pharmaceuticals and agrochemicals.